Clinical Trial Search

Primary: Analyses of Covariance to Test for Group Differences (MDD vs. Healthy) on Clinician-rated Depression Severity After 16 Weeks of Behavioral Activation Psychotherapy…

Primary: Primary Motor Cortex (M1) Excitability Derived From Stimulus Response Curve — 4.68; 9.09; 5.01; 8.04 millivolts

Primary: Energy Intake — 1016.1; 245.1 kcal/day — p=0.01

Primary: Change From Baseline to Week 8 in Weekly Mean of the Average Daily (24-hour) Pain Intensity Score for FX006 60 mg vs TCA IR 40 mg — -3.9; -3.4 units on a scale — p=0.1249

Primary: Changes in Small Nerve Fiber Density by Assessment of a Skin Biopsy Comparing Baseline to Day 60 — .1; .1 nerve fibers / mm squared

Primary: Left Ventricular Global Strain Rate — 18; 23 percentage of change

Primary: Number of Participants With Complete Remission — 41; 20 Participants

Primary: Change in Levels of CD8+ T-cell Activation (Defined as the Percentage HLA-DR+/CD38+) From Baseline to Weeks 24 and 48 on ART — -4.01 % of CD8+ T-cells — p=0.001

Primary: Synovial Fluid Drug Concentrations (pg/mL) by Time Point Pooled Across FX006 Cohorts and TCA IR in Synovial Fluid — 1.0; 1.0; 231328.9; 3590.0 pg/mL

Primary: Number of Synovial Markers Showing a Reduction From Baseline Following Treatment at Days 45 and 90 — 6; 6; 8; 5 protein markers

Primary: Area Under the Curve From Day 1 to Day 3 (AUC1-3 Days) of Pain Intensity(PI) on Movement for Diclofenac/Methanol Gel and Placebo Gel — 276.97; 282.88 NRS Score (0 - 10…

Primary: Comparison of Pain Intensity and Unpleasantness Postoperatively — 4.82; 4.83; 4.05; 4.81 units on a scale

Primary: Number of Patients Who Receive Preoperative Vancomycin and Cefazolin Who Develop a Surgical Site Infection Compared to Those Whose Received Only Cefazolin. — 0; 0…

Primary: Percentage of Participants With Clinically Relevant Bleeding During Treatment — 8; 11; 6; 6 percentage of participants

Primary: Participant Retention Rate Over 12 Months — 352; 125 participants